Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
In Neuroscience 2026, this session introduces the basics and latest developments in Neuroscience, focusing on how the brain and nervous system work. It explains the role of Neurons, brain signals, and brain functions in controlling behaviour, thinking, and body activities.
It also covers how Brain science is helping in understanding and treating conditions like Stroke, Stress, Addiction, and Trauma-related disorders. New technologies like AI, brain imaging, and diagnostics are also discussed for improving research and patient care.
Tracks:
Track 1.1: Basic Neuroscience
Track 1.2: Cognitive Neuroscience
Track 1.3: Clinical Neuroscience
Track 1.4: AI in Neuroscience
Track 1.5: Brain Imaging
In Neuroscience 2026, this session offers a broad perspective on contemporary psychiatric care, highlighting how brain function influences a range of mental health conditions. It explores clinical approaches to managing disorders such as depression and anxiety, while also considering the effects of trauma and addiction. The discussion further includes recent developments in psychotherapy, pharmacological treatments, and digital mental health innovations.
Tracks:
Track 2.1: Clinical Psychiatry & Mental Health
Track 2.2: Depression, Anxiety & Mood Disorders
Track 2.3: Schizophrenia & Psychotic Disorders
Track 2.4: Bipolar Disorder & Personality Disorders
In Neuroscience 2026, this session delves into the core foundations of Neurobiology, examining how the nervous system operates from molecular interactions to complex neural networks. It brings together insights from Neuroscience, Psychiatry, and Brain science to explore brain signaling, connectivity, and disease pathways. Special focus is given to Stroke, Stress, and Trauma Care, along with the functional role of Neurons in health and disease. The session also addresses behavioural aspects such as Addiction, aiming to advance diagnostic and therapeutic strategies.
Tracks:
Track 3.1: Neural signaling and synaptic transmission
Track 3.2: Brain plasticity and neurodevelopment
Track 3.3: Molecular mechanisms of neurological disorders
Track 3.4: Neuroinflammation and neurodegeneration
Track 3.5: Advances in neuroimaging and brain mapping
In Neuroscience 2026, this session centred on cognitive processes, examines how the brain drives thinking, memory, attention, and decision-making. It highlights how neural systems shape behaviour and influence mental health outcomes. Special focus is given to the effects of conditions such as stroke, stress, trauma, and addiction on cognitive function, along with emerging approaches to improve assessment, diagnosis, and treatment of cognitive disorders.
Tracks:
Track 4.1: Cognitive functions and brain mechanisms
Track 4.2: Learning and memory processing
Track 4.3: Attention and perception systems
Track 4.4: Language and executive functions
In Neuroscience 2026, this session focusing on the brain’s adaptability and explores how neural systems reorganize in response to experience, learning, and injury. Drawing from Brain science and Psychiatry, it highlights the dynamic nature of Neurons and their crucial role in Mental health. Particular attention is given to recovery following Stroke and Trauma Care, as well as the impact of Stress and Addiction on neural remodeling and rehabilitation outcomes.
Tracks:
Track 5.1: Mechanisms of synaptic plasticity
Track 5.2: Brain development and adaptive learning
Track 5.3: Neurogenesis and neural regeneration
Track 5.4: Cortical reorganization after injury
In Neuroscience 2026, this session highlights the genetic blueprint underlying brain function and behaviour, examining how gene variations influence neural development and the role of Neurons in mental health. Integrating Neuroscience and Psychiatry, it explores the connections between genetics, Stroke, Stress, Trauma Care, and Addiction. Advances in epigenetics, genome analysis, and targeted therapies are presented as key drivers of personalized approaches in neurological care.
Tracks:
Track 6.1: Genetic architecture of the brain
Track 6.2: Gene expression in neural development
Track 6.3: Epigenetics and brain function
Track 6.4: Genome-wide association studies (GWAS)
Track 6.5: Inherited neurological disorders
In Neuroscience 2026, this session dedicated to visualizing the living Brain, and presents advanced imaging technologies that reveal structure, function, and neural connectivity. Integrating insights from Neuroscience and Psychiatry, it enhances understanding of Neurons and Mental health conditions. Applications in Stroke, Stress-related disorders, Trauma Care, and Addiction are explored, alongside AI-driven innovations for accurate diagnosis and treatment planning.
Tracks:
Track 7.1: Brain imaging techniques
Track 7.2: MRI and fMRI studies
Track 7.3: PET scan neuroscience
Track 7.4: EEG brain mapping
In Neuroscience 2026, this session focuses on how degenerative brain conditions develop by analyzing the biological pathways responsible for neuronal damage and loss. Bringing together insights from Neuroscience, Psychiatry, and Brain science, it examines the roles of neuroinflammation, chronic stress, and trauma in shaping mental health outcomes. It also explores the effects of Stroke, advances in Trauma Care, and the influence of Addiction, while highlighting new progress in diagnostic biomarkers, neuroimaging, and innovative treatment approaches.
Tracks:
Track 8.1: Pathophysiology of neurodegenerative diseases
Track 8.2: Protein misfolding and aggregation mechanisms
Track 8.3: Oxidative stress and mitochondrial dysfunction
Track 8.4: Neuroinflammation and immune response in the brain
In Neuroscience 2026, this session examines how medications affect the brain by altering neural signaling, behaviour, and overall cognitive function. It explores how targeted treatments interact with neuronal pathways to manage and improve mental health conditions. The discussion also covers therapeutic approaches for addiction and stroke, along with recent progress in precision medicine and advanced drug delivery systems.
Tracks:
Track 9.1: Neuropharmacology & Brain Drug Mechanisms
Track 9.2: Neurotransmitters (Dopamine, Serotonin, Glutamate)
Track 9.3: Receptor Pharmacology & Synaptic Signaling
Track 9.4: Psychopharmacology and Mental Health Disorders
Track 9.5: Depression, Anxiety & Schizophrenia Treatments
In Neuroscience 2026, this session explores the expanding role of psychotherapy in mental health care, focusing on evidence-based methods for treating psychiatric and behavioural conditions. It examines how therapeutic interventions shape emotional and cognitive processes to support recovery and well-being, with particular attention to trauma and stress. The discussion also highlights the integration of traditional techniques with digital innovations to deliver more personalized and culturally responsive care.
Tracks:
Track 10.1: Cognitive Behavioural Therapy (CBT) and Third-Wave Therapies
Track 10.2: Psychodynamic and Psychoanalytic Approaches
Track 10.3: Mindfulness-Based and Stress Reduction Therapies
Track 10.4: Trauma-Informed Therapy and PTSD Treatment
Track 10.5: Child and Adolescent Psychotherapy
In Neuroscience 2026, this session examines the ethical, legal, and societal challenges arising from rapid advancements in brain research and mental health care. It explores concerns around privacy, neurotechnology, and the growing use of AI in clinical settings, while considering their impact on patient rights and care practices. With a focus on trauma and addiction, the session emphasizes responsible innovation, informed consent, and the need for equitable and patient-centered approaches.
Tracks:
Track 11.1: Neuroethics in Research and Clinical Practice
Track 11.2: Brain Privacy and Data Protection
Track 11.3: Ethics of Neurotechnology and AI in Mental Health
Track 11.4: Cognitive Enhancement and Human Augmentation
Track 11.5: Informed Consent and Patient Rights
In Neuroscience 2026, this session showcases the latest developments in neurosurgical practice, focusing on advanced techniques used to treat conditions affecting the brain, spine, and nervous system. It highlights innovations such as minimally invasive procedures, image-guided surgery, and robotic-assisted technologies that improve precision and patient outcomes. The discussion also addresses approaches in trauma and stroke management, emphasizing recovery and rehabilitation strategies.
Tracks:
Track 12.1: Minimally Invasive Neurosurgical Techniques
Track 12.2: Brain Tumor Surgery and Neuro-oncology
Track 12.3: Spine Surgery and Disorders
Track 12.4: Functional Neurosurgery and Deep Brain Stimulation
Track 12.5: Neurotrauma and Critical Care
In Neuroscience 2026, this session examines brain development from infancy through adolescence, focusing on the biological and environmental factors that shape cognitive and emotional growth. It explores how early-life experiences influence long-term outcomes, with particular attention to stress and trauma. The discussion also highlights the importance of early diagnosis, prevention, and timely interventions to support healthy development.
Tracks:
Track 13.1: Brain Development across the Lifespan
Track 13.2: Genetics and Epigenetics in Neurodevelopment
Track 13.3: Neurodevelopmental Disorders (Autism, ADHD, etc.)
Track 13.4: Prenatal and Perinatal Brain Development
Track 13.5: Environmental Influences on Brain Development
In Neuroscience 2026, this session focuses on strategies to restore function and enhance quality of life for individuals affected by neurological conditions and injuries. It highlights advancements in rehabilitation techniques, adaptive recovery processes, and coordinated care approaches that support overall well-being. The discussion emphasizes innovative methods to improve outcomes, with particular attention to stroke and trauma recovery.
Tracks:
Track 14.1: Stroke Rehabilitation and Recovery
Track 14.2: Neuroplasticity and Functional Recovery
Track 14.3: Traumatic Brain Injury (TBI) Rehabilitation
Track 14.4: Spinal Cord Injury Rehabilitation
Track 14.5: Physical, Occupational, and Speech Therapy
In Neuroscience 2026, this session showcases emerging technologies that are reshaping the understanding and treatment of neurological conditions. It explores innovations such as brain–computer interfaces, advanced imaging methods, and AI-based tools that enhance diagnosis and therapy. The discussion highlights real-world applications and the integration of these advancements into clinical practice, with a focus on stroke and trauma.
Tracks:
Track 15.1: Brain–Computer Interfaces (BCI)
Track 15.2: Neuroimaging and Brain Mapping Technologies
Track 15.3: Artificial Intelligence in Neuroscience
Track 15.4: Wearable and Implantable Neural Devices
Track 15.5: Neuromodulation Techniques (TMS, DBS)
In Neuroscience 2026, this session explores how data-driven approaches are transforming the study of brain function and mental health. It highlights the use of computational tools, large-scale data analysis, and modeling techniques to better understand neurological conditions. The discussion emphasizes collaboration and data sharing to accelerate innovation, with a focus on data science, artificial intelligence, and big data.
Tracks:
Track 16.1: Brain Data Analysis and Modeling
Track 16.2: Computational Neuroscience Methods
Track 16.3: Big Data and Machine Learning in Neuroscience
Track 16.4: Neuroimaging Data Processing and Integration
Track 16.5: Brain Mapping and Connectomics
In Neuroscience 2026, this session focuses on the use of medications in treating neurological and mental health conditions, highlighting how drugs interact with the body to improve symptoms and overall functioning. It explores recent progress in drug development, mechanisms of action, and personalized treatment approaches aimed at enhancing effectiveness and safety. The discussion also considers practical strategies for patient care, with a focus on pharmacology, therapeutics, and precision medicine.
Tracks:
Track 17.1: Mechanisms of Psychotropic Drugs
Track 17.2: Antidepressants, Antipsychotics, and Mood Stabilizers
Track 17.3: Personalized and Precision Psychiatry
Track 17.4: Drug Development and Clinical Trials
Track 17.5: Pharmacokinetics and Pharmacodynamics
In Neuroscience 2026, this session examines the dynamic relationship between the nervous and hormonal systems, focusing on how chemical signals influence mood, behaviour, and overall brain function. It explores key regulatory pathways and their role in health and disease, along with emerging research and treatment approaches. The discussion highlights important connections with hormones and behaviour.
Tracks:
Track 18.1: Brain–Hormone Signaling Mechanisms
Track 18.2: Hypothalamic–Pituitary Axis Function
Track 18.3: Stress, Cortisol, and Neuroendocrine Responses
Track 18.4: Hormones and Mood Disorders
Track 18.5: Neuroendocrinology of Reproduction
In Neuroscience 2026, this session focuses on the identification and use of measurable indicators to improve early detection, track disease progression, and enhance treatment outcomes in brain-related conditions. It explores advances in research techniques and innovative tools that support more accurate diagnosis and monitoring of disorders, including stroke and addiction. The discussion emphasizes the role of biomarkers, imaging, and genetics in enabling more precise and personalized care.
Tracks:
Track 19.1: Molecular and Genetic Biomarkers
Track 19.2: Neuroimaging Biomarkers
Track 19.3: Fluid Biomarkers (Blood, CSF)
Track 19.4: Digital and Wearable Biomarkers
Track 19.5: Biomarkers in Neurodegenerative Diseases
In Neuroscience 2026, this session focuses on the latest research and clinical approaches to understanding and managing schizophrenia. It explores advances in early detection, treatment strategies, and personalized care to improve patient outcomes and quality of life. The discussion highlights key aspects of mental health, the impact of stress, and the role of neurons in shaping symptoms and recovery.
Tracks:
Track 20.1: Neurobiology and Pathophysiology of Schizophrenia
Track 20.2: Early Detection and Intervention Strategies
Track 20.3: Antipsychotic Treatments and Innovations
Track 20.4: Cognitive and Behavioural Therapies
Track 20.5: Genetic and Environmental Risk Factors
In Neuroscience 2026, this session focuses on the mechanisms, diagnosis, and treatment of anxiety disorders, integrating Neuroscience, Psychiatry, and Brain science to understand their impact on the Brain and Mental health. It highlights the role of Neurons, along with psychological and environmental factors, in the development of anxiety. The session explores advances in pharmacological and psychotherapeutic interventions, as well as strategies for managing Stress and prevention. It also addresses links to conditions such as Addiction and comorbidities like Stroke, with relevance to Trauma Care, aiming to improve overall well-being.
Tracks:
Track 21.1: Neurobiology of Anxiety Disorders
Track 21.2: Generalized Anxiety, Panic, and Phobias
Track 21.3: Stress Response and Coping Mechanisms
Track 21.4: Cognitive Behavioural Therapy for Anxiety
Track 21.5: Pharmacological Treatments for Anxiety